FDA Grants Priority Review to Pfizer’s RSV Vaccine Candidate for Older Americans
December 08, 2022

The FDA has granted priority review to a biologics license application for Pfizer’s respiratory syncytial virus vaccine candidate, RSVpreF, for adults aged ≥60 years.

Pfizer-BioNTech Seek EUA for Omicron Booster in Children Aged Under 5 Years
December 06, 2022

Pfizer and BioNTech submitted an application to the FDA for emergency use authorization of their omicron BA.4/BA.5-adapted bivalent COVID-19 vaccines in children aged 6 months to 4 years.

Daily Dose: Parent-Pediatrician Vaccine Discussions Lagging?
November 29, 2022

Your daily dose of clinical news you may have missed.

Parent-Pediatrician Vaccine Discussions are Lagging, National Poll Finds
November 28, 2022

One in 7 parents have not discussed vaccines with their child's primary clinician during the 2-year pandemic period, according to a CS Mott Children's Hospital poll.

Investigational Fentanyl Vaccine Could Block the Opioid from the Brain
November 15, 2022

A vaccine against fentanyl could stop the intense euphoria the drug creates and also block dangerous physiologic responses like respiratory depression, a new study suggests.

Vaccine Confidence Significantly Eroded During Pandemic, Across Demographics
November 10, 2022

Confidence in vaccines is lower post-pandemic across all demographic groups and is not limited to traditional "anti-vaxxers," say authors of a new study.

Pediatric RSV Vaccines: Why Are We Still Waiting?
November 08, 2022

I have admitted infants to the hospital every winter for 40 years, yet I still don't have good answers for anxious parents watching their child struggling to breathe.

Maternal RSV Vaccine Prevents Infection in Infants, Pfizer Announces
November 02, 2022

Topline phase 3 trial data showed 81.8% efficacy for the maternal vaccine against severe RSV-related illness in infants from birth through first 90 days of life.

Adult RSV Vaxx Gets EMA Nod: Can USA be Far Behind?
October 28, 2022

The GSK RSV vaccine candidate has received favorable international regulatory attention which may be an auspicious sign for the US.

Daily Dose: Recombinant Zoster Vaccine Provides 10 Years of Protection
October 26, 2022

Your daily dose of clinical news you may have missed.